Achondroplasia is the most common type of short-limb short stature. It is a genetic disorder that affects bone growth.
Individuals with achondroplasia have disproportionate short stature and certain characteristic features. Intellect is typically normal.
It is estimated that one in 22,000 people are born with achondroplasia. Occurrences of achondroplasia are present among all racial groups and affects both males and females equally.
Achondroplasia is a condition one is born with. It can sometimes be diagnosed before birth by antenatal ultrasound scans in the third trimester.
The severity of symptoms may vary from person to person, even among family members with achondroplasia.
The main features include:
The following issues can also be present in individuals with achondroplasia and need to be monitored for and treated if present:
Genes are instructions for cells to make proteins in the body. Achondroplasia is the result of a pathogenic (disease-causing) change in the FGFR3 gene located on chromosome 4.
This gene provides instructions for a protein that is important for bone growth. When there is a pathogenic change in the FGFR3 gene, the protein is affected and bone development is impacted.
This causes affected individuals to be short, with shortened upper limbs, hands and feet. Bones in the spine and legs are also at risk of curving.
Everyone carries two copies of each gene, one inherited from each parent.
Achondroplasia follows a dominant inheritance pattern, which means that a pathogenic change in one copy of the FGFR3 gene can cause achondroplasia. If one parent has achondroplasia, a child has a 50% chance of inheriting the disease.
About 80% of people with achondroplasia have parents who are of average height, while the remaining 20% have at least one parent who has achondroplasia.
Achondroplasia is diagnosed following a comprehensive evaluation by a healthcare professional with expertise in skeletal dysplasias. The diagnostic process includes a detailed clinical assessment, radiological imaging and, , genetic testing.
Voxzogo (vosoritide) is a drug approved for the treatment of children with achondroplasia.. It has been shown to improve annual growth rate in children with achondroplasia and promote proportional growth.
The multidisciplinary medical team looking after your child will be able to address specific medical concerns and related health issues.
Below are some related medical issues and how they can be managed:
Medical issue | Treatment |
---|---|
Middle ear dysfunction |
|
Obstructive sleep apnoea and/or restrictive pulmonary disease |
|
Kyphosis and spinal stenosis |
|
Hydrocephalus |
|
Craniocervical junction constriction |
|
Obesity |
|
In 80% of cases, achondroplasia is the result of a spontaneous change in the genetic material of the sperm or egg at conception, in families with no previous history of the condition.
People with achondroplasia typically have a normal life expectancy. However, they may face complications that require ongoing medical care, such as spinal stenosis, hydrocephalus and orthopaedic issues. With proper treatment and care, individuals with achondroplasia can lead active and fulfilling lives.
Support Group |
---|
Little People of America |
MAGIC Foundation |
Club Rainbow Singapore |
Download the Achondroplasia brochure.
Achondroplasia - orthoinfo -AAOS. OrthoInfo. (n.d.). https://orthoinfo.aaos.org/en/diseases--conditions/achondroplasia/
Anzilotti, A. W. (Ed.). (2022, April). Achondroplasia (for parents) | nemours kidshealth. KidsHealth. https://kidshealth.org/en/parents/achondroplasia.html
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth.
Get to know our doctors at SingHealth Hospitals in Singapore.
Get to know our doctors at SingHealth Hospitals in Singapore. here.